ARTICLE | Financial News
PhaseBio raises $34M series D
September 7, 2018 7:51 PM UTC
PhaseBio Pharmaceuticals Inc. (Malvern, Pa.) raised $34 million in a series D round from new investors Cormorant Asset Management, Rock Springs Capital and Mountain Group Partners. Existing investors New Enterprise Associates, Hatteras Venture Partners, AstraZeneca plc (NYSE:AZN; LSE:AZN), Johnson & Johnson Innovation - JJDC Inc., Syno Capital and Fletcher Spaght Ventures also participated. ...
BCIQ Company Profiles